unknown
Stage
2
Investors
About
Coherence Neuro develops SOMA, a therapeutic neurotechnology platform — a coin-sized wireless brain implant, an over-ear wearable, and an app — that continually monitors and delivers personalized neurostimulation to manage cancer by disrupting tumor bioelectric signaling.
Explore Coherence Neuro's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.